Loading content...

Checking access...

The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial
Dickon Hayne
University of Western Australia

Dickon Hayne discusses the safety of sub-urothelial injection of durvalumab and examine the impact on tissue and circulating immune cell populations.

Transcript

Topic Overview

Try PhD level

Ask Faculti AI: Explore the transcript or get definitions

Loading...

Related Videos

Queen Mary University of London

DNA methylation predicts high-grade cervical neoplasia

University of Bath

Shared Genetic Architecture in Anorexia Nervosa

Imperial College London

Gene therapy for heart failure: The end of the beginning?

Imperial College London

Large Stem Cell-Derived Cardiomyocyte Grafts: Cellular Ventricular Assist Devices?